YXYeyu Xiao

Yeyu Xiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yeyu Xiao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Fangfang Deng

    Guangzhou University of Chinese Medicine

    3 shared publications
  • Renhua Wu

    Department of Radiology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.

    3 shared publications
  • Zhen Cao

    Department of Medical Imaging, The Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China

    3 shared publications
  • Zhi-Wei Shen

    Department of Medical Imaging, The Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China

    3 shared publications
  • Zhuyin Zhang

    Guangzhou University of Chinese Medicine

    3 shared publications
  • Jingyao Yang

    Department of Radiology Guangzhou Hospital Of Integrated Traditional And Western Medicine Guangzhou University of Chinese Medicine China

    2 shared publications

Latest Publications

  • Open Access

    Uncertainty-aware feature mapping and adaptive inference for brain tumor segmentation with missing contrast-enhanced T1-weighted imaging

    by Weidong Liu, Zhuyin Zhang, Fangfang Deng, Yeyu Xiao

    Introduction: Multi-parametric magnetic resonance imaging (mpMRI) is a cornerstone of clinical brain tumor assessment, yet the contrast-enhanced T1-weighted (T1ce) sequence is frequently unavailable due to contrast-agent contraindications or acquisition failures. Existing segmentation methods degrade substantially when key modalities are missing, motivating the need for robust missing-modality segmentation frameworks. Methods: We propose UAF-AIMM (Uncertainty-Aware Feature Mapping and Adaptive Inference for Brain Tumor Segmentation with Missing Contrast-Enhanced T1-Weighted Imaging), a 3D brain tumor segmentation framework for the clinically prevalent missing-T1ce scenario. UAF-AIMM integrates three components: (1) MR-Mapper, a cross-modal feature mapping module that recovers T1ce-related semantics in the latent space from observed sequences; (2) Uncertainty-Aware Attention (UAA), which estimates voxel-wise predictive variance and uses learnable gating to fuse features according to their estimated reliability; and (3) Single-Image Test-Time Adaptation (SITA), a per-case calibration strategy that updates only normalization affine parameters to mitigate domain shift at inference. Results: Evaluated on the BraTS (Brain Tumor Segmentation) 2021 dataset under the missing-T1ce protocol, UAF-AIMM achieves an average Dice similarity coefficient of 89.20% and a 95th percentile Hausdorff distance (HD95) of 5.50 mm, outperforming representative baselines including 3D U-Net, Swin UNETR, mmFormer, and ReCoSeg. The improvement is most pronounced in the contrast-dependent enhancing tumor (ET) subregion. Conclusion: The results demonstrate that feature-space compensation with explicit reliability control and test-time calibration provides a practical and effective direction for robust brain tumor segmentation under incomplete multi-modal MRI protocols, with potential for translation to heterogeneous clinical environments.

  • The value of 2D and 3D MRI texture models in Grade II and III anterior cruciate ligament injuries

    by Qian Zhang, Yeyu Xiao, Jingyao Yang, Fangfang Deng, Zhuyin Zhang, Jiahui Cai


  • Open Access

    A novel nomogram based on the patient’s clinical data and CT signs to predict poor outcomes in AIS patients

    by Jingyao Yang, Fangfang Deng, Qian Zhang, Zhuyin Zhang, Qinghua Luo, Yeyu Xiao

    Background: The 2019 American Heart Association/American Stroke Association (AHA/ASA) guidelines strongly advise using non-contrast CT (NCCT) of the head as a mandatory test for all patients with suspected acute ischemic stroke (AIS) due to CT’s advantages of affordability and speed of imaging. Therefore, our objective was to combine patient clinical data with head CT signs to create a nomogram to predict poor outcomes in AIS patients. Methods: A retrospective analysis was conducted on 161 patients with acute ischemic stroke who underwent mechanical thrombectomy at the Guangzhou Hospital of Integrated Traditional and Western Medicine from January 2019 to June 2023. All patients were randomly assigned to either the training cohort (n = 113) or the validation cohort (n = 48) at a 7:3 ratio. According to the National Institute of Health Stroke Scale (NIHSS) score 7 days after mechanical thrombectomy, the patients were divided into the good outcome group ( 6 (OR 7.707; 95% CI [2.201–26.991]; P = 0.001), NIHSS score (OR 1.085; 95% CI [1.009–1.166]; P = 0.027), age (OR 1.077; 95% CI [1.020–1.138]; P = 0.008) and white blood cell count (WBC) (OR 1.200; 95% CI [1.008–1.428]; P = 0.040) were independent risk factors for early poor outcomes after mechanical thrombectomy. The nomogram model was constructed based on the above factors. The training set achieved an AUC of 0.894, while the validation set had an AUC of 0.848. The bootstrapped ROC AUC estimates were 0.905 (95% CI [0.842–0.960]) for the training set and 0.848 (95% CI [0.689–0.972]) for the validation set. Results from the Hosmer-Lemeshow goodness-of-fit test and calibration plot indicated consistent performance of the prediction model across both training and validation cohorts. Furthermore, the DCA curve demonstrated the model’s favorable clinical practicality. Conclusion: This study introduces a novel practical nomogram based on HMCAS, ASPECTS > 6, NIHSS score, age, and WBC that can well predict the probability of poor outcomes after MT in patients with AIS.


  • Open Access

    Parsimonious clinical prediction model for the diagnosis of complicated appendicitis

    by Jia-Hui Cai, Hui Zhou, Dan Liang, Qiao Chen, Yeyu Xiao, Guang-Ming Li


  • Synthesis and in vitro antiproliferative activities of lupanol derivatives towards human esophageal squamous carcinoma cells

    by Weijie Li, Yeyu Xiao

    A series of lupanol derivatives were synthesized and evaluated in vitro for their inhibitory activities against three human esophageal squamous carcinoma cells lines, Eca-109, TE-1 and EC-9706. Among lupanol derivatives, seven were new compounds, and lupanol cinnamate analogues 5 and 6, hydrazone analogues 9 and 10 presented high activities towards all the tested tumour cells, even higher activities than those of doxorubicine. Graphical Abstract

  • Open Access

    Adenoviral vector mediated ferritin over-expression in mesenchymal stem cells detected by 7T MRI in vitro

    by Hai-Yang Dai, Rong He, Ying Zhang, Ren-Hua Wu, Ye-Yu Xiao

    The aim of the present work was to verify whether adenoviral vector mediated ferritin over-expression in mesenchymal stem cells could be detected by 7T MRI device, and to explore the relationship between ferritin content and MRI signal intensities. A recombined adenoviral vector (rAdV) encoding ferritin heavy chain (FTH1) subunit was specially designed for the aim of infecting bone marrow mesenchymal stem cells (BMSCs). Ferritin over-expression in BMSCs was determined by cell immunocytochemistry and the ferritin content in cells was determined by ELISA assay. BMSCs were subjected to cell viability, proliferation and multi-differentiation analyses as well as 7T MRI test using fast spin-echo pulse sequence. The R2 value andδR2 were calculated according to T2 mapping images. As was confirmed by cell immunocytochemistry and ELISA assay, rAdV mediated ferritin was over-expressed in BMSCs. Ferritin over-expression did not interfere with stem cell viability or pluripotent differentiation but slowed cell proliferation. The R2 value of BMSCs-FTH1 vs control BMSCs from 1–4 weeks was16.65±1.28 s-1 vs 13.99±0.80 s-1, (t = 3.94, p = 0.004), 15.63±1.37 s-1 vs 13.87±0.83 s-1 (t = 2.47, p = 0.039), 15.53±0.88 s-1 vs 14.25±0.53 s-1 (t = 2.80, p = 0.023) and 14.61±1.28 s-1 vs 13.69±1.03 s-1 (t = 1.25, p = 0.24), respectively. δR2 gradually decreased from 1–4 weeks and the difference between the groups had statistical significance (F = 12.45, p<0.01).δR2 was positively correlated with OD value (r = 0.876, p<0.01) and ferritin concentration (r = 0.899, p<0.01) as determined by Pearson correlation. Our study confirms that ferritin could be over-expressed in BMSCs as a result of rAdV mediated infection and could be quantitatively detected by 7T MRI device. The differences in T2 signal intensities and R2 values stem from internal contrast generated by endogenous ferritin over-expression. The correlation between δR2, OD and ferritin concentration suggests that MRI can detect ferritin signal change accurately.


  • Synthesis and in vitro antitumour activities of lupeol derivatives

    by Weijie Li, Yeyu Xiao

    Nine lupeol derivatives were synthesised and assayed in vitro for their antitumour activities against three human tumour cells lines, A549, LAC and HepG2. Of lupeol derivaties, six were new compounds, and five compounds against A549 cells, four compounds against HepG2 cells and three compounds against LAC cells were effective in reducing viability, and the most promising compounds 5, 6 and 9 exhibited high activities against lung and liver cancer cells, even higher activities than those of adriamycin.


  • Open Access

    Alterations in brain metabolism and function following administration of low-dose codeine phosphate: 1H-magnetic resonance spectroscopy and resting-state functional magnetic resonance imaging studies

    by Zhen Cao, Pei-Yin Lin, Zhi-Wei Shen, Ren-Hua Wu, Ye-Yu Xiao

    The aim of the present study was to identify alterations in brain function following administration of a single, low-dose of codeine phosphate in healthy volunteers using resting-state functional magnetic resonance imaging (fMRI). In addition, the metabolic changes in the two sides of the frontal lobe were identified using 1H-magnetic resonance spectroscopy (1H-MRS). A total of 20 right-handed healthy participants (10 males, 10 females) were evaluated, and a Signa HDx 1.5T MRI scanner was used for data acquisition. An echo planar imaging sequence was used for resting-state fMRI, whereas a point resolved spectroscopy sequence was used for 1H-MRS. Regional Saturation Technique, Data Processing Assistant for Resting-State fMRI, and Statistical Parameter Mapping 8 were used to analyze the fMRI data. The 1H-MRS data were analyzed using LCModel software. At 1 h after oral administration of codeine phosphate (1.0 mg/kg), the amplitude of low-frequency fluctuation (ALFF) and regional homogeneity were altered in different brain areas. The choline content was significantly increased in the right and left frontal lobes following codeine phosphate administration (P=0.02 and P=0.03, respectively), whereas the inositol content was significantly decreased in the left frontal lobe (P=0.02). There was no change in the glutamic acid content in the frontal lobes. In conclusion, the functions of different brain regions can be affected by a single, low-dose administration of codeine phosphate. The alterations in metabolite content in the two frontal lobes may be associated with changes in brain function, whereas the ALFF in the globus pallidus may have an effect on codeine phosphate addiction. Finally, glutamic acid may be useful in the estimation of codeine dependence.


  • 7.0 T high-resolution 1H-MR spectroscopy of metabolic changes induced by chronic codeine phosphate in rat hippocampus

    by Zhen Cao, Pei-Yin Lin, Zhi-Wei Shen, Ye-Yu Xiao, Ren-Hua Wu

    Codeine phosphate is used widely to treat cough and pain. It is actually a sedative, but is known to cause codeine dependence. The exact mechanisms of codeine dependence are not fully understood, but are generally believed to be related to drug-induced neuroadaptation. Metabolites changes can provide information for pathological processes and mechanisms before the shape change. It is very useful for the diagnosis and treatment of drug addiction. We used 1H NMR spectroscopy in vivo to measure the concentrations of cerebral metabolites in the hippocampus of rats subjected to repeated codeine treatment. After 2 months of codeine treatment, the concentration of N-acetylaspartate was significantly decreased in hippocampi, as was that of glutamate, choline, and taurine. Our study highlights the potential use of metabolic profiling to enhance our understanding of metabolite alteration associated with codeine dependence.


  • Open Access

    2D-1H proton magnetic resonance spectroscopic imaging study on brain metabolite alterations in patients with diabetic hypertension

    by Zhen Cao, Bi-Di Ye, Zhi-Wei Shen, Xiao-Fang Cheng, Zhong-Xian Yang, Yan-Yan Liu, Ren-Hua Wu, Kuan Geng, Ye-Yu Xiao

    The aim of the present study was to investigate the possible metabolic alterations in the frontal cortex and parietal white matter in patients with diabetic hypertension (DHT) using proton magnetic resonance (MR) spectroscopic imaging. A total of 33 DHT patients and 30 healthy control subjects aged between 45 and 75 were included in the present study. All subjects were right‑handed. The spectroscopy data were collected using a GE Healthcare 1.5T MR scanner. The multi‑voxels were located in the semioval center (repetition time/echo time=1,500 ms/35 ms). The area of interest was 8x10x2 cm in volume and contained the two sides of the frontal cortex and the parietal white matter. The spectra data were processed using SAGE software. The ratios of brain metabolite concentrations, particularly for N‑acetylaspartate (NAA)/creatine (Cr) and Choline (Cho)/Cr were calculated and analyzed. Statistical analyses were performed using SPSS 17.0. The NAA/Cr ratio of the bilateral prefrontal cortex of the DHT group was significantly lower than that of the control group (left t=‑7.854, P=0.000 and right t=‑5.787, P=0.000), The Cho/Cr ratio was also much lower than the control group (left t=2.422, P=0.024 and right t=2.920, P=0.007). NAA/Cr ratio of the left parietal white matter of the DHT group was extremely lower than that of the control group (t=‑4.199, P=0.000). Therefore, DHT may result in metabolic disorders in the frontal cortex and parietal white matter but the metabolic alterations are different in various regions of the brain. The alteration in cerebral metabolism is associated with diabetes and hypertension. The ratios of NAA/Cr and Cho/Cr are potential metabolic markers for the brain damage induced by DHT.